A novel 3D ex vivo platform of fresh patient tumor tissue with intact tumor microenvironment for immuno-oncology drug development and biomarker discovery

被引：0
|
作者：
Mediavilla-Varela, Melanie [1 ]
Page, Melba Marie [1 ]
Kreahling, Jenny [1 ]
Antonia, Scott [1 ]
Altiok, Soner [1 ]
机构：
[1] Nilogen Oncosyst, Tampa, FL USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P468
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Employing ex vivo 3D-Screen technology for the development of rational combinations of immuno-oncology drugs in tumor organoids of fresh patient tissue
    Agrawal, Vijayendra
    Pabon, Mibel M.
    Ehrhart, Jared C.
    Pastoor, Tina
    Kreahling, Jenny M.
    Altiok, Soner
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [2] The importance of intact tumor immune microenvironment in unpropagated 3D fresh patient tumoroids in immuno-oncology drug testing for immunogenic tumor cell death and T-cell activation
    Agrawal, Vijayendra
    Mediavilla-Varela, Melanie
    Page, Melba Marie
    Kreahling, Jenny
    Altiok, Soner
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [3] A novel ex vivo 3D tumor organoid model of fresh patient tumors (3D-ACT) to assess efficacy of cellular therapy in immuno-oncology
    Agrawal, Vijayendra
    Pabon, Mibel
    Page, Melba Marie
    Kreahling, Jenny
    Altiok, Soner
    [J]. MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [4] Expanding the 3D ex vivo patient tissue platform toolbox for (immuno)-oncology drug testing
    Beztsinna, Nataliia
    Basten, Sander
    Aksoy, Ezgi Kaya
    Meesters, Niels
    Timiliotis, Stefanos
    van der Meer, Donny
    Yan, Kuan
    Spanjaard, Emma
    Vader, Willemijn
    Price, Leo S.
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [5] Immunotherapy testing in 3D Ex vivo Patient Tissue Platform with preserved tumor microenvironment
    Beztsinna, Nataliia
    Meesters, Niels
    Daszkiewicz, Lidia
    Grillet, Fanny
    van der Meer, Donny
    Yan, Kuan
    Spanjaard, Emma
    Vader, Willemijn
    Price, Leo
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [6] Leveraging artificial intelligence to advance immuno-oncology drug development using functional ex-vivo 3D-tumor organoid platforms of fresh patient tissue samples
    Kreahling, Jenny
    Santiago, Daniel
    Agrawal, Vijayendra
    Pabon, Mibel
    Altiok, Soner
    Page, Melba
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [7] DETERMINING THE EFFICACY OF ADCC BY THE 3D-EX EX VIVO PLATFORM UTILIZING TUMOROIDS OF FRESH PATIENT TUMOR SAMPLES WITH INTACT TUMOR MICROENVIRONMENT
    Kreahling, Jenny
    Ehrhart, Jared
    Iwanowycz, Stephen
    Pabon, Mibel
    Pastoor, Tina
    Altiok, Soner
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A336 - A336
  • [8] Novel patient avatar platform for oncology drug testing using 3D ex vivo models derived from fresh patient tumor tissues
    Beztsinna, Nataliia
    Grillet, Fanny
    Meesters, Niels
    van der Meer, Donny
    Daszkiewicz, Lidia
    Yan, Kuan
    Spanjaard, Emma
    Vader, Willemijn
    Price, Leo
    [J]. MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [9] Functional 3D-plEX quantitative multiplex immunofluorescence platform to assess IO drug impact on tumor microenvironment in ex vivo treated intact 3D-tumor organoids of fresh patient tumor tissue
    Kreahling, Jenny
    Agrawal, Vijayendra
    Page, Melba
    Pabon, Mibel
    Altiok, Soner
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [10] Developmentof a murine tumor immunophenotyping platform to support drug discovery anddevelopment in immuno-oncology
    Belmontes, Brian
    Matyas, Stephanie
    O'Brien, Sarah
    Tan, Hong
    Ganley, Kenneth
    Merriam, Kimberly
    Rottman, Jim
    Egen, Jackson
    Beltran, Pedro
    Moody, Gordon
    [J]. CANCER RESEARCH, 2016, 76
12345